Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations.
Evgenii ShumilovJohanna FlachRaphael JoncourtNaomi PorretGertrud WiedemannAnne Angelillo-ScherrerLorenz TrümperMartin FiedlerBarbara JekerUrsula AmstutzThomas PabstVera Ulrike BacherPublished in: Hematological oncology (2019)